Roche Holding AG (LTS:0QOK)
CHF 263.05 -1.65 (-0.62%) Market Cap: 211.30 Bil Enterprise Value: 236.93 Bil PE Ratio: 19.78 PB Ratio: 7.21 GF Score: 86/100

Roche Holding AG ASH Medical Congress Virtual Event Transcript

Dec 14, 2022 / 03:00PM GMT
Release Date Price: CHF305.5 (-0.88%)
Operator

(Operator Instructions) One last remark, if you would like to follow the presented slides on your end as well, feel free to go to roche.com/investors to download the presentation. At this time, it's my pleasure to introduce you to Bruno Eschli, Head of Investor Relations. Bruno, the stage is yours.

Bruno Eschli
Roche Holding AG - Head of IR

Thanks, Henrik, for the introduction. Can I have the first slide, please?

So welcome to our last IR call for this year, where we would like to provide you an in-depth insight in our growing hematology franchise. And let me first quickly take you for today's agenda. We have several speakers with us joining. The first section will be with Peter Ahnesorg. Peter is our Franchise Head, hematology and Global Product Strategy, and he will present our malignant and nonmalignant hematology strategy and the overall portfolio.

The second part then goes to Charles Fuchs, our Global Head of Oncology and Hematology and Product Development, and Charlie will take you through the key data presented at ASH '22. And finally

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot